T. Rowe Price Associates’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $200K | Buy |
10,692
+201
| +2% | +$3.76K | ﹤0.01% | 2713 |
|
|
2025
Q1 | $191K | Buy |
10,491
+1,023
| +11% | +$18.6K | ﹤0.01% | 2660 |
|
|
2024
Q4 | $207K | Buy |
9,468
+1,647
| +21% | +$36K | ﹤0.01% | 2659 |
|
|
2024
Q3 | $215K | Buy |
+7,821
| New | +$215K | ﹤0.01% | 2629 |
|
|
2021
Q3 | – | Sell |
-1,410
| Closed | -$221K | – | 2943 |
|
|
2021
Q2 | $221K | Buy |
+1,410
| New | +$221K | ﹤0.01% | 2686 |
|